Alpelisib Completed Phase 1 Trials for Hepatic Impairment Basic Science

IndicationsStatusPurposePhase
CompletedBasic Science1
clinicaltrials.gov IdentifierTitleDrugs
NCT02624557Pharmacokinetic Study of Alpelisib in Subjects With Hepatic Impairment.